ANIMATION

Vasopressin V2-Receptor Blockage

Share this article with:

Hyponatremia is a condition characterized by low sodium concentration in blood serum. This may be caused by overactivity of anti-diuretic hormone, which results in increased reabsorption of water from the collecting duct. Tolvaptan is an FDA-approved antagonist of the vasopressin V2-receptor. Inhibition of this receptor prevents the expression of aquaporin channels along the collecting duct, promoting diuresis and correcting sodium levels in serum.

Share It:
Contact XVIVO

Client


Otsuka

The XVIVO groups combination of scientific and design expertise means their work is unmatched and of a high standard. We were very pleased with the final product and it has been well received by audiences across the globe. We would absolutely recommend working with XVIVO.

Jeremy Moon, CEO Icebreaker